Market Overview

Lipocine (NASDAQ: LPCN)

2.87 0.00 (0.00%)

Earnings

QuarterPriorEstimateActualSurprise
Q2 2020
Pre-Market
EPS:
REV:
-0.14
0



Q1 2020
Pre-Market
EPS:
REV:
-0.14
0



Q4 2019
Pre-Market
EPS:
REV:
-0.15



Q3 2019
Pre-Market
EPS:
REV:
-0.12



Q2 2019
Pre-Market
EPS:
REV:
-0.15
0
-0.16
-0.14
0
12.5%
Q1 2019
Pre-Market
EPS:
REV:
-0.13
428.031K
-0.14
-0.14
0
0%
Q4 2018
Pre-Market
EPS:
REV:
-0.25
-0.13
-0.15
15.38%
Q3 2018
Pre-Market
EPS:
REV:
-0.22
-0.24
-0.12
-50%
Q2 2018
Pre-Market
EPS:
REV:
-0.31
-0.25
-0.15
-40%
Q1 2018
Pre-Market
EPS:
REV:
-0.26
-0.21
-0.13
428.031K
-38.1%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!